“Nephrotic Syndrome With Sunitinib-Associated Focal Segmental Glomerulosclerosis in a Patient With Renal Carcinoma: Partial Reversibility After Dose Adjustment: Case Report”. 2025. Revista De La Sociedad Ecuatoriana De Nefrología, Diálisis Y Trasplante 13 (2): 149-56. https://doi.org/10.56867/118.